Everyone should put a few things into perspective. The HIV drug market alone is worth $35 BILLION, and Clone-3 has shown to be 2.6 times greater in neutralization potency over ANY existing anti-body out there. Simply put, we could easily corner the market. We are going to blow the competition right out of the water. Clone 3 is effective with 41 out of the 43 existing HIV strains (95%).
While you try wrapping your head around this information think about this, not only do we have an antibody (Clone 3) but we also have a vaccine (ITV-1) in preclinical trials that can target HIV and Hepatitis C.
Hepatitis C is a $8 BILLION dollar market. This is just some of the applicability. Factor in the addressable market of COVID 19 and other viruses that our technologies may target and we may be looking at a total addressable market of >$100+ BILLION.
It is absolutely not wild to speculate a PPS greater than +++$1 on this information alone. We have research and ground to cover, but an opportunity does not get sweeter than this. I expect to at least 10x by end of year, and 1000x longer-term. I don't typically believe in unicorns, but I am ready to saddle up and ride this one through.
Take the Red Pill , and you can go back to your 9-5 and will soon realize the incomprehensible size of an opportunity missed when the PPS punches a hole through the ceiling. You will be depressed for a while but will eventually get back in the game daytrading junk stocks for several years to come wishing a similar play of this magnitude comes around again.
Take the Green Pill , and you could be looking at a very comfortable early retirement. One play, thats all it takes. I will show you how deep this rabbit hole goes.
Choose wisely.
$ENZC
